WHO Expert Committee on Biological Standardization

World Health Organization - Technical Report Series

Volumn , Issue 941, 2007, Pages

  Van Aken, W G ^a   Dobbelaer, R ^b   Fuchs, F ^c   Grachev, V ^d   Homma, A ^d   Kurata, T ^e   Lower J ^f   Minor, P ^g   Reigel, F ^h   Vyas, G N ⁱ   Spieser, J M ^j   Buchheit, K H ^j   Jadhav, S ^k   Bayer, H ^l   Dahl, P ^m   Eshkol, A ⁿ   Forest, J C ^a  

^a Scientific Institute of Public Health Louis Pasteur ^*  (Canada)

^b Scientific Institute of Public Health Louis Pasteur   (Belgium)

^c CHUMAKOV INSTITUTE OF POLIOMYELITIS AND VIRAL ENCEPHALITIDES   (Russian Federation)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

^e PAUL EHRLICH INSTITUT   (Germany)

^f NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^g Swissmedic   (Switzerland)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j Serum Institute of India Ltd   (India)

^k ROCHE DIAGNOSTICS GMBH   (Germany)

^l Eye Bank for Sight Restoration   (United States)

^m Serono International SA   (Switzerland)

ⁿ LAVAL UNIVERSITY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANTIGEN; BCG VACCINE; BIOLOGICAL PRODUCT; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; CYANOCOBALAMIN; CYTOKINE; DIPHTHERIA ANTIBODY; DNA VACCINE; FOLIC ACID; INACTIVATED VACCINE; INFLUENZA VACCINE; KERATINOCYTE GROWTH FACTOR; LIVE VACCINE; PERTUSSIS VACCINE; POLYSACCHARIDE; PROTHROMBIN; RABIES IMMUNOGLOBULIN; RABIES VACCINE; ROTAVIRUS VACCINE; SMALLPOX VACCINE; SNAKE VENOM ANTISERUM; THROMBOCYTE ANTIGEN; THROMBOPLASTIN; VASCULOTROPIN; VIRUS ANTIBODY; YELLOW FEVER VACCINE;

BIOLOGICAL THERAPY; BIOSAFETY; BIOTECHNOLOGY; BLOOD; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CONFERENCE PAPER; DEGRADATION; DENGUE VIRUS; DEVICE; DIPLOIDY; EPIDEMIC ENCEPHALITIS; FIBROBLAST; FOOD AND DRUG ADMINISTRATION; FRACTIONATION; GENE THERAPY; GERMANY; GOOD MANUFACTURING PRACTICE; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH PROGRAM; HEMOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; IN VITRO STUDY; JAPAN; JAPANESE ENCEPHALITIS VIRUS; LABORATORY; MALARIA; MEASLES; MEDICAL RESEARCH; MENINGOCOCCOSIS; NETHERLANDS; NONHUMAN; PERTUSSIS; PLASMA; POLIOMYELITIS VIRUS; PRACTICE GUIDELINE; PRION DISEASE; QUALITY CONTROL; RABBIT; RED CROSS; REGULATORY MECHANISM; SAMPLE; SERUM; STANDARDIZATION; STREPTOCOCCUS PNEUMONIA; TEMPERATURE; TETANUS; THROMBOSIS; TRANSPLANTATION; TUBERCULOSIS; UNITED KINGDOM; UNITED STATES; VIRULENCE; VIRUS INFECTION; WHOLE CELL; WORLD HEALTH ORGANIZATION; YELLOW FEVER;

EID: 39649111951     PISSN: 05123054     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (0)